B Rajendra Krishnan

Title: Inventor B Rajendra Krishnan – Pioneering Research in Neospora Proteins

Introduction

B Rajendra Krishnan, an inventor based in East Lyme, Connecticut, has made significant contributions to the field of biotechnology. With two patents to his name, his work revolves around developing innovative solutions to combat neosporosis, a disease affecting livestock and posing risks to human health.

Latest Patents

Krishnan's latest patents showcase his expertise in polynucleotide molecules. One of the notable inventions involves isolated polynucleotide molecules that encode GRA, SAG, MIC, and MAG proteins from Neospora. This invention includes recombinant vectors, transformed host cells, and extensively studied recombinantly-expressed proteins. Additionally, he has developed genetic constructs based on these polynucleotide molecules, which are crucial for preparing modified strains of Neospora cells for vaccines against neosporosis.

The second patent focuses on DNA encoding Neospora dihydrofolate reductase-thymidylate synthase (DHFR-TS). This invention provides isolated polynucleotide molecules containing sequences that are advantageous for creating modified live vaccines against neosporosis and serves as diagnostic reagents. It further includes cloning and expression vectors, transformed host cells, and highly pure DHFR-TS proteins and peptide fragments.

Career Highlights

Throughout his career, B Rajendra Krishnan has worked with prestigious companies, including Pfizer Corporation. His experience in the biotechnology sector has allowed him to advance his research and secure patents that contribute to vaccine development.

Collaborations

Krishnan has collaborated with notable individuals such as Becky A Durtschi and S Christine Yoder. These partnerships have enabled him to enhance his research and promote innovative ideas within the scientific community.

Conclusion

B Rajendra Krishnan stands out as a prominent inventor in the field of biotechnology, particularly in relation to neosporosis. His patents reflect a deep commitment to scientific advancement and provide necessary tools for future vaccine development. His innovative contributions continue to impact research and public health positively.